Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.8800 (8.63%) ($6.1600 - $6.8800) on Tue. Dec. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.09% (three month average) | RSI | 51 | Latest Price | $6.8800(8.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.4% a day on average for past five trading days. | Weekly Trend | EYES declines -0.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) IGOV(8%) TAN(8%) UNG(7%) FIVG(4%) FXI(4%) | Factors Impacting EYES price | EYES will decline at least -2.045% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) QQQ(-6%) LQD(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.045% (StdDev 4.09%) | Hourly BBV | 0 () | Intraday Trend | 11.7% | | | |
|
Resistance Level | $6.92 | 5 Day Moving Average | $6.98(-1.43%) | 10 Day Moving Average | $6.93(-0.72%) | 20 Day Moving Average | $6.92(-0.58%) | To recent high | -10.4% | To recent low | 18.5% | Market Cap | $2.198b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |